Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I M Morison

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pathology|January 29, 2005
Imprinting, expression, and localisation of DLK1 in Wilms tumoursR Fukuzawa, R W Heathcott, I M Morison, et al.
Journal of the American College of Cardiology|August 1, 1997
Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone: preliminary studyM J Williams, I M Morison, J H Parker, et al.
Human Molecular Genetics|December 1, 1993
Human insulin-like growth factor type I and type II receptors are not imprintedO Ogawa, L A McNoe, M R Eccles, et al.
Oncogene|January 13, 2009
Canonical WNT signalling determines lineage specificity in Wilms tumourR Fukuzawa, M R Anaka, R J Weeks, et al.
Nature Medicine|March 1, 1996
Somatic overgrowth associated with overexpression of insulin-like growth factor III M Morison, D M Becroft, T Taniguchi, et al.
Journal of Medical Genetics|February 25, 1998
Is p57KIP2 mutation a common mechanism for Beckwith-Wiedemann syndrome or somatic overgrowth?K Okamoto, I M Morison, A E Reeve, et al.
Oncogene|August 17, 1995
Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumourT Taniguchi, A E Schofield, J L Scarlett, et al.
The New Zealand Medical Journal|January 7, 1998
Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosisM J Burt, J D Upton, I M Morison, et al.
The New Zealand Medical Journal|May 11, 2001
Dietary iron intakes and biochemical iron status of 15-49 year old women in New Zealand: is there a cause for concern?E L Ferguson, I M Morison, J M Faed, et al.
The Journal of Pathology|May 20, 2008
Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changesR Fukuzawa, M R Anaka, R W Heathcott, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pathology|January 29, 2005
Imprinting, expression, and localisation of DLK1 in Wilms tumoursR Fukuzawa, R W Heathcott, I M Morison, et al.
Journal of the American College of Cardiology|August 1, 1997
Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone: preliminary studyM J Williams, I M Morison, J H Parker, et al.
Human Molecular Genetics|December 1, 1993
Human insulin-like growth factor type I and type II receptors are not imprintedO Ogawa, L A McNoe, M R Eccles, et al.
Oncogene|January 13, 2009
Canonical WNT signalling determines lineage specificity in Wilms tumourR Fukuzawa, M R Anaka, R J Weeks, et al.
Nature Medicine|March 1, 1996
Somatic overgrowth associated with overexpression of insulin-like growth factor III M Morison, D M Becroft, T Taniguchi, et al.
Journal of Medical Genetics|February 25, 1998
Is p57KIP2 mutation a common mechanism for Beckwith-Wiedemann syndrome or somatic overgrowth?K Okamoto, I M Morison, A E Reeve, et al.
Oncogene|August 17, 1995
Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumourT Taniguchi, A E Schofield, J L Scarlett, et al.
The New Zealand Medical Journal|January 7, 1998
Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosisM J Burt, J D Upton, I M Morison, et al.
The New Zealand Medical Journal|May 11, 2001
Dietary iron intakes and biochemical iron status of 15-49 year old women in New Zealand: is there a cause for concern?E L Ferguson, I M Morison, J M Faed, et al.
The Journal of Pathology|May 20, 2008
Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changesR Fukuzawa, M R Anaka, R W Heathcott, et al.
Pageof 3